Journal of Genetics

, Volume 93, Issue 2, pp 557–560 | Cite as

A novel de novo mutation of β-cardiac myosin heavy chain gene found in a twelve-year-old boy with hypertrophic cardiomyopathy

  • SEIGO OKADA
  • YASUO SUZUKI
  • TAKURO ARIMURA
  • AKINORI KIMURA
  • HIROKO NARUMI
  • SHUNJI HASEGAWA
RESEARCH NOTE
First Online:
Received:
Revised:
Accepted:

Keywords

HCM MYH7 point mutation de novo pediatrics 
This is a preview of subscription content, log in to check access.

References

  1. Choi J. O., Yu C. W., Nah J. C., Park R. J., Lee B. S., Choi J. Y., et al. 2010 Long-term outcome of 4 Korean families with hypertrophic cardiomyopathy caused by 4 different mutations. Clin. Cardiol. 33, 430–438.PubMedCrossRefGoogle Scholar
  2. Fananapazir L. and Epstein N. D. 1994 Genotype-phenotype correlations in hypertrophic cardiomyopathy. Insights provided by comparisons of kindreds with distinct and identical beta-myosin heavy chain gene mutations. Circulation 89, 22–32.PubMedCrossRefGoogle Scholar
  3. Franz W. M., Muller O. J., and Katus H. A. 2001 Cardiomyopathies: From genetics to the prospect of treatment. Lancet 358, 1627–1637.PubMedCrossRefGoogle Scholar
  4. García-Castro M., Coto E., Reguero J. R., Berrazueta J. R., Alvarez V., Alonso B., et al. 2009 Mutations in sarcomeric genes MYH7, MYBPC3, TNNT2, TNNI3, and TPM1 in patients with hypertrophic cardiomyopathy. Rev. Esp. Cardiol. 62, 48–56.PubMedCrossRefGoogle Scholar
  5. Ho C. Y. and Seidman C. E. 2006 A contemporary approach to hypertrophic cardiomyopathy. Circulation 113, e858–862.PubMedCrossRefGoogle Scholar
  6. Kimura A. 2010 Molecular basis of hereditary cardiomyopathy: abnormalities in calcium sensitivity, stretch response, stress response and beyond. J. Hum. Genet. 55, 81–90.PubMedCrossRefGoogle Scholar
  7. Kubo T., Kitaoka H., Okawa M., Baba Y., Hirota T., Hayato K., et al. 2011 Genetic screening and double mutation in Japanese patients with hypertrophic cardiomyopathy. Circ. J. 75, 2654– 2659.PubMedCrossRefGoogle Scholar
  8. Maron B. J. 2002 Hypertrophic cardiomyopathy: A systematic review. JAMA 287, 1308–1320.PubMedGoogle Scholar
  9. Maron B. J., Cecchi F., and McKenna W. J. 1994 Risk factors and stratification for sudden cardiac death in patients with hypertrophic cardiomyopathy. Br. Heart J. 72, 13–18.CrossRefGoogle Scholar
  10. Maron B. J., Estes N. A. 3rd., Maron M. S., Almquist A. K., Link M. S., and Udelson J. E. 2003 Primary prevention of sudden death as a novel treatment strategy in hypertrophic cardiomyopathy. Circulation 107, 2872–2875.PubMedCrossRefGoogle Scholar
  11. Maron B. J., Maron M. S., and Semsarian C. 2012 Genetics of hypertrophic cardiomyopathy after 20 years: Clinical perspectives . J. Am. Coll. Cardiol. 60, 705–715.PubMedCrossRefGoogle Scholar
  12. Melacini P., Maron B. J., Bobbo F., Basso C., Tokajuk B., Zucchetto M., et al. 2007 Evidence that pharmacological strategies lack efficacy for the prevention of sudden death in hypertrophic cardiomyopathy. Heart 93, 708–710.PubMedCentralPubMedCrossRefGoogle Scholar
  13. Otsuka H., Arimura T., Abe T., Kawai H., Aizawa Y., Kubo T., et al. 2012 Prevalence and distribution of sarcomeric gene mutationsin Japanese patients with familial hypertrophic cardiomyopathy. Circ. J. 76, 453–461.PubMedCrossRefGoogle Scholar
  14. Richard P., Charron P., Carrier L., Ledeuil C., Cheav T., Pichereau C., et al. 2003 Hypertrophic cardiomyopathy: Distribution of disease genes, spectrum of mutations, and implications for a molecular diagnosis strategy. Circulation 107, 2227–2232.PubMedCrossRefGoogle Scholar
  15. Towbin J. A. 2000 Molecular genetics of hypertrophic cardiomyopathy. Curr. Cardiol. Rep. 2, 134–140.PubMedCrossRefGoogle Scholar
  16. Towbin J. A. and Bowles N. E. 2002 The failing heart. Nature 415, 227–233.PubMedCrossRefGoogle Scholar
  17. Van Driest S. L., Jaeger M. A., Ommen S. R., Will M. L., Gersh B. J., Tajik A. J., et al. 2004 Comprehensive analysis of the beta-myosin heavy chain gene in 389 unrelated patients with hypertrophic cardiomyopathy. J. Am. Coll. Cardiol. 44, 602–610.PubMedCrossRefGoogle Scholar
  18. Van Driest S. L., Ommen S. R., Tajik A. J., Gersh B. J., and Ackerman M. J. 2005 Sarcomeric genotyping in hypertrophic cardiomyopathy. Mayo Clin. Proc. 80, 463–469.PubMedCrossRefGoogle Scholar
  19. Wang S., Zou Y., Fu C., Xu X., Wang J., Song L., et al. 2008 Worse prognosis with gene mutations of beta-myosin heavy chain than myosin-binding protein C in Chinese patients with hypertrophic cardiomyopathy. Clin. Cardiol. 31, 114–118.PubMedCrossRefGoogle Scholar
  20. Watkins H., Rosenzweig A., Hwang D. S., Levi T., McKenna W., Seidman C. E., et al. 1992 Characteristics and prognostic implications of myosin missense mutations in familial hypertrophic cardiomyopathy. New Engl. J. Med. 326, 1108–1114.PubMedCrossRefGoogle Scholar

Copyright information

© Indian Academy of Sciences 2014

Authors and Affiliations

  • SEIGO OKADA
    • 1
  • YASUO SUZUKI
    • 1
  • TAKURO ARIMURA
    • 2
  • AKINORI KIMURA
    • 2
  • HIROKO NARUMI
    • 1
  • SHUNJI HASEGAWA
    • 1
  1. 1.Department of PediatricsYamaguchi University Graduate School of MedicineYamaguchiJapan
  2. 2.Department of Molecular Pathogenesis, Medical Research InstituteTokyo Medical and Dental UniversityTokyoJapan

Personalised recommendations